Shan Wu
Corporate Officer/Principal at VIRIDIAN THERAPEUTICS, INC.
Shan Wu active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Corporate Officer/Principal | 2023-10-29 | - |
Career history of Shan Wu
Former positions of Shan Wu
| Companies | Position | Start | End |
|---|---|---|---|
| MAGENTA THERAPEUTICS | Investor Relations Contact | 2021-09-30 | 2023-08-31 |
| Corporate Officer/Principal | 2021-09-30 | 2023-08-31 |
Training of Shan Wu
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Virginia | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Shan Wu
- Experience
